Verve gene-editing therapy lowers cholesterol without serious side effects in early study Company previously paused development of an earlier treatment due to safety concerns

https://www.statnews.com/2025/04/14/verve-102-gene-editing-therapy-cholesterol-phase-1-study-safety/